Kindred Biosciences, Inc.KINNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
10.49%
↓ 98% below average
Average (8y)
516.95%
Historical baseline
Range
High:4087.47%
Low:-28.60%
Volatility
796.2%
High variability
| Period | Value |
|---|---|
| 2020 | 10.49% |
| 2019 | 7.24% |
| 2018 | 49.44% |
| 2017 | 27.44% |
| 2016 | -28.60% |
| 2015 | 3.84% |
| 2014 | 495.24% |
| 2013 | 4087.47% |
| 2012 | 0.00% |